TLDR Charles Hoskinson confirmed that Cardano is in talks with WLFI to bring the USD1 stablecoin to the network. The USD1 stablecoin already operates on Ethereum BNB and Tron and it holds a market cap of 2.67 billion dollars. Hoskinson revealed that IOG Chief of Staff J.J. Siler is leading discussions with WLFI CEO Zach [...] The post Cardano Founder Confirms Talks on USD1 Stablecoin and Chainlink Deals appeared first on CoinCentral.TLDR Charles Hoskinson confirmed that Cardano is in talks with WLFI to bring the USD1 stablecoin to the network. The USD1 stablecoin already operates on Ethereum BNB and Tron and it holds a market cap of 2.67 billion dollars. Hoskinson revealed that IOG Chief of Staff J.J. Siler is leading discussions with WLFI CEO Zach [...] The post Cardano Founder Confirms Talks on USD1 Stablecoin and Chainlink Deals appeared first on CoinCentral.

Cardano Founder Confirms Talks on USD1 Stablecoin and Chainlink Deals

TLDR

  • Charles Hoskinson confirmed that Cardano is in talks with WLFI to bring the USD1 stablecoin to the network.
  • The USD1 stablecoin already operates on Ethereum BNB and Tron and it holds a market cap of 2.67 billion dollars.
  • Hoskinson revealed that IOG Chief of Staff J.J. Siler is leading discussions with WLFI CEO Zach Witkoff.
  • Cardano is also negotiating a potential integration with Chainlink despite high cost challenges for the partnership.
  • Hoskinson praised Chainlink founder Sergey Nazarov and emphasized the strategic value of Chainlink technology.

Cardano founder Charles Hoskinson announced new partnership talks that could reshape the Cardano ecosystem. He confirmed ongoing discussions with WLFI’s USD1 stablecoin and Chainlink. He also highlighted Cardano’s need for cross-chain integration to stay competitive.

USD1 Stablecoin Could Join Cardano

Hoskinson revealed that Cardano is negotiating to bring WLFI’s USD1 stablecoin to the network. He said Cardano “can land that deal” and added that discussions were progressing. According to him, J.J. Siler is handling talks with WLFI CEO Zach Witkoff.

The USD1 stablecoin runs on Ethereum, BNB, and Tron networks. It launched in March and quickly gained adoption. With a $2.67 billion market cap, it currently ranks fifth among stablecoins.

If the deal succeeds, USD1 would become the largest stablecoin on Cardano. This move would expand liquidity and improve network activity. Hoskinson emphasized that such progress is key for Cardano’s relevance.

Hoskinson also confirmed that Cardano is in talks with Chainlink. He admitted the process may take longer because of high costs. He said the LINK team gave “an absurd number for integration.”

Nevertheless, Hoskinson said Cardano will “handle it” and “figure it out.” He praised Chainlink founder Sergey Nazarov as “extremely smart” and a skilled negotiator. He also described Chainlink as holding “a golden egg.”

Chainlink recently gained visibility through its collaboration with the US Department of Commerce. The project now delivers economic data on-chain. This growth reflects why Cardano considers Chainlink a strategic partner.

Hoskinson Pushes Cross-Chain Deals for Cardano

Hoskinson also mentioned plans to engage with Aave. He said, “I’d like USD1, I’d like Aave, I’d like Chainlink.” He called these projects a “bundle” Cardano is working to secure.

He explained that partnerships would help Cardano meet global standards. He gave the example of the US government choosing Chainlink for economic data needs. He argued Cardano must reach similar capabilities to succeed.

Hoskinson insisted that Cardano must keep pace with rapid industry changes. He concluded that cross-chain partnerships are essential for Cardano’s future growth. He stressed that these alliances could define Cardano’s competitive edge.

The post Cardano Founder Confirms Talks on USD1 Stablecoin and Chainlink Deals appeared first on CoinCentral.

Market Opportunity
Binance Coin Logo
Binance Coin Price(BNB)
$929,18
$929,18$929,18
-0,90%
USD
Binance Coin (BNB) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23